Case number 1:21-cv-01001
Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. ยง 652(b). Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(Taylor, Daniel) |
| Dec 29, 2021 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Dec 15, 2021 | 24 | Order (4) Docket Text: CERTIFIED TRANSFER ORDER - issued by the Panel on the Multi-District Litigation on 12/10/2021. Associated Cases: 1:21-md-03017-RGA et al. (nmg) |
| Dec 15, 2021 | N/A | Remark - MDL Member (0) Docket Text: NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:21-md-03017-RGA et al. (nmg) |
| Dec 15, 2021 | N/A | Remark - MDL Notice to Counsel (0) Docket Text: NOTICE TO COUNSEL: MDL No. 1:21-md-3017 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents and are not registered, should register for E-filing rights through PACER. Please see the docket for further entries. Associated Cases: 1:21-md-03017-RGA et al. (nmg) |
| Nov 9, 2021 | 23 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva's Rule 26(a)(1) Initial Disclosures filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 27, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference scheduled for 10/28/2021, is CANCELED. Ordered by Judge Richard G. Andrews on 10/27/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms) |
| Oct 27, 2021 | 21 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. The case will be referred to a Magistrate Judge to handle all discovery disputes. The actions are consolidated for all purposes, including trial, and all papers shall be filed in C.A. 21-314 only. Joinder of Parties due by 8/5/2022. Amended Pleadings due by 3/1/2022. Fact Discovery completed by 10/28/2022. Joint Claim Construction Brief due by 8/5/2022. A Markman Hearing is set for 8/23/2022, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 5/19/2023, at 8:30 AM in Courtroom 6A. A Bench Trial is set to start 5/30/2023 at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 10/27/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms) |
| Oct 27, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynge and her Law Clerk, Daniel Taylor (daniel_taylor@ded.uscourts.gov), to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 10/27/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(Taylor, Daniel) |
| Oct 27, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(Taylor, Daniel) |
| Oct 26, 2021 | 20 | Main Document (15) Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Blumenfeld, Jack) Modified on 10/26/2021 (nms). |
| Oct 26, 2021 | 20 | Letter to The Honorable Richard G. Andrews (1) |
| Sep 27, 2021 | 19 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 10/28/2021, at 2:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/27/2021. (nms) |
| Sep 9, 2021 | 18 | Answer to Counterclaim (8) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaim by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Aug 30, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 18 in 21-cv-1000-RGA; D.I. 17 in 21-cv-1001-RGA; D.I. 19 in 21-cv-314-RGA; D.I. 14 in 21-cv-732-RGA) MOTION for Pro Hac Vice Appearance of Attorney Thomas D. Rein and Andrew T. Langford, filed by Janssen Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 8/30/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms) |
| Aug 27, 2021 | 17 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Thomas D. Rein and Andrew T. Langford - filed by Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Aug 23, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal and Chandrika Vira, filed by Teva Pharmaceuticals USA, Inc., and [15] MOTION for Pro Hac Vice Appearance of Attorney Brady P. Gleason, filed by Teva Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 8/23/2021. (nms) |
| Aug 23, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Brady P. Gleason, Chandrika Vira, J.C. Rozendaal for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Aug 23, 2021 | 16 | Order (4) Docket Text: SO ORDERED Granting [14] Stipulation Dismissal Teva Pharmaceutical Industries, Ltd. (*Party Teva Pharmaceutical Industries Ltd. terminated). Signed by Judge Richard G. Andrews on 8/23/2021. (nms) |
| Aug 20, 2021 | 15 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Brady P. Gleason - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Aug 19, 2021 | 11 | Answer to Complaint (14) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) Modified on 8/23/2021 (nms). |
| Aug 19, 2021 | 12 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Aug 19, 2021 | 13 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal and Chandrika Vira - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Aug 19, 2021 | 14 | Stipulation of Dismissal (4) Docket Text: STIPULATION of Dismissal, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/21/2021 (nms). |
| Aug 11, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 16 in 21-cv-1000-RGA; D.I. 12 in 21-cv-732-RGA; D.I. 10 in 21-cv-1001-RGA) MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Dov P. Grossman, Alexander S. Zolan, Kathryn S. Kayali, and Julie L. Tavares, filed by Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Bayer AG. Signed by Judge Richard G. Andrews on 8/11/2021. Associated Cases: 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms) |
| Aug 11, 2021 | 10 | Motion for Leave to Appear Pro Hac Vice (10) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Dov P. Grossman, Alexander S. Zolan, Kathryn S. Kayali, and Julie L. Tavares - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Jul 30, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION to Extend Time (*Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 8/19/2021). Signed by Judge Richard G. Andrews on 7/30/2021. (nms) |
| Jul 29, 2021 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to move, plead, or otherwise respond the Complaint to August 19, 2021 - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Jul 14, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:21-cv-01000-RGA, 1:21-cv-01001-RGA (rjb) |
| Jul 8, 2021 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Bayer AG. Teva Pharmaceuticals USA, Inc. served on 7/8/2021, answer due 7/29/2021. (Fahnestock, Derek) |
| Jul 7, 2021 | 1 | Main Document (11) Docket Text: COMPLAINT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3652716.) - filed by Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Bayer AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(twk) |
| Jul 7, 2021 | 7 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (twk) |
| Jul 7, 2021 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (twk) |
| Jul 7, 2021 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer Pharma AG. (twk) |
| Jul 7, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (twk) |
| Jul 7, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/16/2021. Date of Expiration of Patent: 1/31/2039. Thirty Month Stay Deadline: N/A. (twk) |
| Jul 7, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Jul 7, 2021 | 1 | Civil Cover Sheet (1) |
| Jul 7, 2021 | 1 | Exhibit A (26) |
| Jul 7, 2021 | 1 | Complaint* (1) |
